REAL-WORLD EVIDENCE ON CLINICAL USE OF A NOVEL ORAL ANTICOAGULANT FOR THE TREATMENT OF ATRIAL FIBRILLATION

被引：0
|
作者：
Verdecchia, P. [1 ]
Lanati, E. P. [2 ]
Verdini, V. [2 ]
Corrao, G. [3 ]
Scotti, L. [3 ]
Airoldi, C. [3 ]
Iorio, A. [2 ]
机构：
[1] Hosp Assisi, Assisi, Italy
[2] MA Provider Srl, Milan, Italy
[3] Univ Milano Bicocca, Milan, Italy
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1373
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV134
引用
收藏
页码：A625 / A625
页数：1
相关论文
共 50 条
  • [41] Real-World Experience of Direct Oral Anticoagulant Use in a Single Pediatric Center
    Guzzardo, Gianna M.
    Sabo, Cynthia
    Rajpurkar, Madhvi
    [J]. BLOOD, 2022, 140 : 5698 - 5699
  • [42] Personalizing oral anticoagulant treatment in patients with atrial fibrillation
    Capranzano, Piera
    Micciche, Eligio
    D'Urso, Lucia
    Privitera, Fiorella
    Tamburino, Corrado
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (08) : 959 - 973
  • [43] Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Cancer
    Olesen, Kevin Kris Warnakula
    Wheeler, Matt
    Eikelboom, John W.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2020, 120 (02) : 194 - 196
  • [44] Real world adherence to oral anticoagulant in non-valvular atrial fibrillation patients in China
    Xiang, Xiao
    Cao, Yaying
    Sun, Kexin
    Song, Jing
    Tian, Yaohua
    Yin, Qiongzhou
    Juan, Juan
    Hu, Yonghua
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (02) : 255 - 261
  • [45] Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy
    Ingrasciotta, Ylenia
    Fontana, Andrea
    Mancuso, Anna
    Ientile, Valentina
    Sultana, Janet
    Uomo, Ilaria
    Pastorello, Maurizio
    Calabro, Paolo
    Ando, Giuseppe
    Trifiro, Gianluca
    [J]. PHARMACEUTICALS, 2021, 14 (04)
  • [46] New oral anticoagulant drugs: real-world data
    Iqbal, Omer
    [J]. PERSONALIZED MEDICINE, 2013, 10 (05) : 419 - 422
  • [47] Cost-effectiveness modelling of novel oral anticoagulants incorporating real-world elderly patients with atrial fibrillation
    Zhao, Ying Jiao
    Lin, Liang
    Zhou, Hui Jun
    Tan, Keng Teng
    Chew, Aik Phon
    Foo, Chee Guan
    Oh, Chia Theng Daniel
    Lim, Boon Peng
    Lim, Wee Shiong
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 794 - 801
  • [48] Atrial fibrillation therapy with new oral anticoagulants: a real world evidence study
    Ferrara, Francesco
    Trama, Ugo
    Nava, Eduardo
    Capuozzo, Maurizio
    Zovi, Andrea
    Valentino, Filomena
    Langella, Roberto
    [J]. INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT, 2023,
  • [49] Gender differences in use of antithrombotic therapy in atrial fibrillation: real-world perspective from the Global Anticoagulant Registry in the FIELD (GARFIELD)
    Lip, G. Y. H.
    Rushton-Smith, S. K.
    Goldhaber, S. Z.
    Fitzmaurice, D. A.
    Mantovani, L. G.
    Goto, S.
    Haas, S.
    Bassand, J. P.
    Mueller, I.
    Kakkar, A. K.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 58 - 58
  • [50] REAL-WORLD EVIDENCE ON THE RISE: EVALUATING THE USE OF REAL-WORLD EVIDENCE IN ICER ASSESSMENTS OF COMPARATIVE CLINICAL EFFECTIVENESS
    Drane, E.
    Upton, E.
    Morten, P.
    Walker, E.
    [J]. VALUE IN HEALTH, 2019, 22 : S316 - S316
12345